Given the heatmap showing a significant increase in its expression in the non-KC group, we hypothesize that the abnormality in CRY2 may impact circadian rhythmicity, leading to metabolic disorders, influencing the normal expression of proteins in corneal tissue, and thus undermining its morphological and structural integrity. Here, CRY2 is linked to metabolic disease.